Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.

Nicole C C Them, Klaudia Bagienski, Tiina Berg, Bettina Gisslinger, Martin Schalling, Doris Chen, Veronika Buxhofer-Ausch, Josef Thaler, Ernst Schloegl, Guenther A Gastl, Dominik Wolf, Karin Strecker, Alexander Egle (Co-author), Thomas Melchardt (Co-author), Sonja Burgstaller, Ella Willenbacher, Oleh Zagrijtschuk, Christoph Klade, Richard Greil (Co-author), Heinz GisslingerRobert Kralovics

Research output: Contribution to journalOriginal Articlepeer-review

41 Citations (Web of Science)
Original languageEnglish
Pages (from-to)288-294
JournalAMERICAN JOURNAL OF HEMATOLOGY
Volume90
Issue number4
DOIs
Publication statusPublished - 2015

Keywords

  • TYROSINE KINASE JAK2
  • CHRONIC HEPATITIS-C
  • ESSENTIAL THROMBOCYTHEMIA
  • MYELOPROLIFERATIVE DISORDERS
  • PEGYLATED INTERFERON-ALPHA-2A
  • MUTATION
  • NEOPLASMS
  • THERAPY
  • MYELOFIBROSIS
  • CRITERIA

Cite this